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Background. Most insights into the cascade of immune events after acute respiratory syncytial virus (RSV) infection have been 
obtained from animal experiments or in vitro models.
Methods. In this study, we investigated host gene expression profiles in nasopharyngeal (NP) swabs and whole blood samples 
during natural RSV and rhinovirus (hRV) infection (acute versus early recovery phase) in 83 hospitalized patients <2 years old with 
lower respiratory tract infections.
Results. Respiratory syncytial virus infection induced strong and persistent innate immune responses including interferon sig-
naling and pathways related to chemokine/cytokine signaling in both compartments. Interferon-α/β, NOTCH1 signaling pathways 
and potential biomarkers HIST1H4E, IL7R, ISG15 in NP samples, or BCL6, HIST2H2AC, CCNA1 in blood are leading pathways 
and hub genes that were associated with both RSV load and severity. The observed RSV-induced gene expression patterns did not 
differ significantly in NP swab and blood specimens. In contrast, hRV infection did not as strongly induce expression of innate 
immunity pathways, and significant differences were observed between NP swab and blood specimens. 
Conclusions. We conclude that RSV induced strong and persistent innate immune responses and that RSV severity may be 
related to development of T follicular helper cells and antiviral inflammatory sequelae derived from high activation of BCL6.
Keywords. children under 2 years old; host expression profile; lower respiratory tract infections; respiratory syncytial virus; 
rhinovirus.
 
Respiratory syncytial virus (RSV) is the leading cause of 
lower respiratory tract infections (LRTIs) in young children. 
Although some risk factors associated with severe RSV disease 
have been identified (prematurity, underlying lung or heart 
diseases, immunodeficiencies), the majority of children with 
RSV that require hospitalization were previously healthy and 
lacked comorbidities [1, 2]. The pathogenesis of RSV remains 
poorly understood, and no vaccines are available. Microarray 
techniques provide an excellent hypothesis-generating tool to 
explore the expression patterns of transcripts across entire bio-
logical pathways during the course of disease [3]. The advent of 
microarray technologies enables investigating the host factors 
involved in the immediate response to infection and those that 
modulate RSV disease severity. Several RSV host expression 
profiling studies have been conducted using in vitro models 
[4–10], animal models [11–15], and human subjects [16–22]. 
However, most in vivo studies only investigated systemic tran-
scriptional profiles in blood [17–19, 21, 22], with only 1 study 
exploring local respiratory expression profiles by analysis of 
nasopharyngeal (NP) aspirates of hospitalized children (n = 30) 
[23], and 1 study, using an animal model, exploring overlap-
ping components of respiratory and systemic responses [15]. 
Because the burden of RSV disease is greatest amongst children 
<2, and because patterns of RSV pathogenesis in young chil-
dren are likely to differ significantly from immune responses 
of adults or animal models, specimens from pediatric cohorts 
represent a priority for in-depth analysis.
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In this study, we applied microarray technology to acute and 
early recovery blood and NP swabs obtained from children 
<2 years hospitalized for LRTI with laboratory-confirmed RSV 
or rhinovirus (hRV) infections, which was reported as a second 
pathogen found in this population [24].
Using a combination of weighted gene coexpression network 
analysis (WGCNA) [25] and conventional analysis approaches 
[26], this unique data set allowed us to compare local and sys-
temic host responses with RSV and hRV infections and to cor-
relate these to clinical outcomes to identify key genes involved 
in RSV pathogenesis and severity.
MATERIALS AND METHODS
Ethics
The following Institutional Review Boards approved the 
study: Children’s Hospitals (CH)1 and 2 and the Hospital for 
Tropical Diseases (Ho Chi Minh City, Vietnam) and the Oxford 
University Tropical Research Ethics Committee (Oxford, UK). 
Written informed consent was obtained from parents or legal 
guardians of children before enrollment into the study.
Study Design, Setting, and Population
The clinical data and samples for gene expression profiling were 
collected from a previously reported cohort of 632 children with 
LRTI under 2 years of age hospitalized at CH1 and CH2 [24]. 
Severe cases were defined as being hospitalized in the intensive 
care unit or requiring supplemental oxygen/mechanical venti-
lation or having a peripheral capillary oxygen saturation (SpO2) 
<92%. In brief, at admission (acute phase) and discharge or day 
7 of hospitalization (early recovery), blood was collected in eth-
ylenediaminetetraacetic acid (EDTA), and PAXgene ribonucleic 
acid (RNA) tubes (PreAnalytiX, Hombrechtikon, Switzerland) 
and 2 NP swabs (Copan Diagnostics Inc, Murrieta, CA) were 
collected in RNAlater (Sigma, Singapore) and viral transport 
medium (VTM) [27]. Nasopharyngeal swabs in RNAlater and 
blood in PAXgene RNA tubes were processed for host gene 
expression profile analyses. The EDTA tubes and the NP swabs 
in VTM were processed for blood count and detection of 14 
respiratory viruses, including RSV and hRV [28–30]. Based on 
the results of the viral detection on NP swabs at admission, and 
the availability of paired samples, 343 cases were selected and 
classified into 3 groups for the current study: single-RSV group 
(RSVsi) (n = 177 of 343, 52%), RSV coinfection group (RSVco) 
(n = 88 of 343, 26%), and single-hRV group (hRV) (n = 78 of 
343, 22%) (Supplementary Figure 1). The RSV group includes 
patients from RSVsi and RSVco.
Gene Expression Profiling by Microarray
Total RNAs from whole blood and NP swabs were extracted 
using the PAXgene blood RNA isolation kit (PreAnalytiX) and 
the RNeasy Mini kit (QIAGEN, Hilden, Germany), respec-
tively. Biotinylated amplified complementary RNA (cRNA) was 
generated by in vitro transcription of total RNA using Ambion 
Illumina TotalPrepRNA amplification kit (Ambion Inc., Austin, 
TX), according to the manufacturer’s instructions. After purifi-
cation, 800 ng of cRNA from NP samples and 2000-ng labeled 
cRNA from blood were hybridized to the HumanHT-12 v4 
BeadChip array at 55°C for 18 hours and under washing, block-
ing, and streptavidine-Cy3 staining steps, according to the 
manufacturer’s instructions. Each array on the HumanHT-12 
v4 Expression BeadChip targets more than 31 000 annotated 
genes with 47 231 probes derived from the National Center for 
Biotechnology Information Reference Sequence RefSeq Release 
38 (November 7, 2009) and other sources. The array was scanned 
using an iScan confocal scanner (Illumina Inc., San Diego, CA).
Preprocessing and Quality Control of Microarray Data
Using R statistical software version 3.2.1 (R Development Core 
Team) [31], raw expression data files from the Illumina iScan 
system were preprocessed using Bioconductor lumi package 
[32] for quality control, background correction, transforma-
tion, and normalization (robust spline normalization algo-
rithm). The ArrayQualityMetric package [33] was used for 
summarizing quality of metrics data and detecting outlier 
arrays that differed substantially from other arrays in the data-
set [34]. If an array from paired samples of a given patient was 
removed, this patient and all associated data were also removed 
from the final analysis. Based on the quality control analysis, 
only 83 cases were processed for the final microarray anal-
ysis (4 arrays from every case, 332 arrays), RSVsi (n  =  38 of 
83, 46%), RSVco (n = 15 of 332, 18%), and hRV (n = 30 of 83, 
36%) (Supplementary Figure  1 and Supplementary Table  1). 
After normalization and filtering, the expression data of NP 
and blood consisted of transcript levels for 30 020 and 24 228 
probes, respectively, being processed for downstream analysis 
of differentially expressed genes (DEGs) and WGCNA. Gene 
expression data are available at the GEO database (https://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97743) under 
accession number GSE97743.
Identification of Differentially Expressed Genes 
To investigate differences in gene expression between 2 time 
points (early recovery versus acute phase) for each group (RSV, 
RSVsi, RSVco, and hRV), the linear modeling framework in 
the limma package [26] was used. A DEG was defined by a fold 
change ≥2 or ≤−2 and Benjamini-Hochberg false discovery rate 
corrected P < .05. Due to the design of Illumina BeadArray, 
there were multiple probes for each gene, reflecting the possi-
bility of multiple differentially spliced transcripts for each gene. 
We collapsed this information as such that each probe repre-
sented an average transcript for each gene.
Weighted Gene Coexpression Network Analysis
The WGCNA uses a stepwise analytical process to interrogate 
variations in gene coexpression patterns across all samples in 
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the same group (RSV or hRV infection) to identify subsets 
of coexpressed genes with similar transcriptional patterns 
together to form a group of transcripts (coexpressed network 
modules). Because the probability for multiple transcripts to 
follow a complex pattern of expression across all the samples by 
chance is low, such sets of genes should constitute coherent and 
biologically meaningful transcriptional units. The coexpressed 
network modules that correlate to a clinical trait are assumed to 
have a coordinated biological function in the clinical condition 
under study (disease status) (Supplementary Table 1 represents 
clinical traits of patients at acute phase and early recovery 
phase) [25]. We focused on groups of transcripts significantly 
correlated to clinical and laboratory parameters that have been 
previously implicated in RSV outcomes [24] and that were also 
differentially expressed during RSV infection.
Functional Enrichment Analysis
For the biological interpretation of gene lists and WGCNA 
modules, InnateDB pathway analysis [35] and g:Profiler [36] 
were used to identify significantly enriched pathways.
Protein-Protein Interaction Network
To obtain insights into the interaction between DEGs of 
selected modules, a protein-protein interactions (PPIs) net-
work was constructed by NetworkAnalyst [37] using the IMEx 
Interactome database [38]. The pipeline of data analysis is sum-
marized in Supplementary Figure 2.
RESULTS
Demographics of Microarray Patients
There were no significant differences in sex and number of 
household members between the 3 selected patient groups as 
well, compared with the original cohort (Table 1). Patients with 
single RSV infection were the youngest group. There were no 
deaths and similar percentages of patients with a history of pre-
mature birth between hRV and single-RSV infection groups. 
It is interesting to note that the RSVco had been significantly 
under steroids treatment (Table 1).
Common Host Transcriptional Responses Across Nasopharyngeal Swab 
Specimens and Blood in Respiratory Syncytial Virus and Rhinovirus 
Infection
Differentially expressed genes were identified in the expres-
sion data of NP swabs and blood of RSVsi (182 DEGs in blood 
and 992 in NP swabs), RSVco (106 DEGs in blood and 479 in 
NP swabs), and hRV (92 DEGs in blood and 325 in NP swabs) 
(Table 2 and Supplementary Table 2).
When DEG lists were compared between NP and blood, 36 
and 43 overlapping DEGs were observed in RSV single and RSV 
coinfection, respectively (Figure 1). When we compared DEGs 
in blood and NP swabs in hRV infection, only 13 overlapping 
DEGs (of 278 DEGs in NP swabs and of 64 DEGs in blood) 
were observed (Figure 1), whereas 44 overlapping DEGs (of 671 
DEGs in NP swabs and of 85 DEGs in blood) were observed 
in all RSV infections. Host expression in blood could not mir-
ror all changes in the airway. For RSV infection in general, 52% 
(44 of 85) of DEGs from peripheral blood reflected 6.5% (44 of 
671) of changes in gene expression in the airways versus 20% 
(13 of 64) and 4.6% (13 of 278), respectively, for hRV infection 
(Figure 1).
Unsupervised hierarchical clustering heatmaps using 
DEGs of RSV and hRV in blood and NP swabs confirmed 
differences in the pattern of gene expression at acute 
phase and early convalescent phase across 4 patient groups 
Table 1. Basic Demographic Characteristics of Microarray Patients
Characteristics
RSVsi
(n = 38)
RSVco
(n = 15)
hRV
(n = 30)
Total
(N1 = 83)
Total cohort
(N2 = 632)
Median age in months (IQR) 6.4 (3.8–11.2) 9.3 (6.8–12.1) 8.15 (3.5–11.95) 7.8 (4.3–11.7) 7 (4–12)
<2 months), n (%) 4 (10.5%) 0 (0%) 2 (6.6%) 6 (7.2%) 41 (6%)
2 to 6 months, n (%) 15 (39.4%) 3 (0.2%) 9 (30%) 27 (32.5%) 277 (44%)
7 to 11 months, n (%) 11 (28.9%) 7 (46.6%) 11 (36.6%) 29 (34.9%) 174 (28%)
12 to 24 months, n (%) 8 (21%) 5 (33.3%) 8 (26.6%) 21 (25.3%) 140 (22%)
Male, n (%) 27 (71%) 10 (66.6%) 19 (63.3%) 56 (67.5%) 430 (68%)
Median number of household members 
(IQR)#8232;
4 (3.7–5) 5 (3–6) 4 (3–6) 4 (3–5) 4 (3–6)
Premature birth, n (%) 4 (10.5%) 0 (0%) 3 (10%) 7 (8.4%) 54/616 (9%)
Use of steroid, n (%) 3 (7.89%) 3 (20%) 3 (10%) 9 (10.8%) 33 (5%)
Mechanical ventilation, n (%) 0 0 0 0 2 (0.3%)
Day of illness (IQR)#8232;
(before admission) (IQR)#8232;
3(3–4) 3(3–4) 2.5 (2–3.25) 3 (2–4) 3 (3–4)
RSV positivity
(at discharge or day 7), n (%)
28 (73.7%) 12 (80%) NA NA 203/302 (67.2%)
Full recovery, n (%) 31 (81.5%) 10 (66%) 19 (63%) 60 (72.3%) 363/596 (61%)
Death, n (%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 2 (0.31%)
Abbreviations: hRV, rhinovirus; IQR, interquartile range; N1, microarray population; N2, population of the original cohort; NA, not applicable; RSV, respiratory syncytial virus; RSVco, RSV 
coinfection group; RSVsi, single-RSV group. 
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(Supplementary Figure 3). These heatmaps also show more 
variability between patients infected by the same virus than 
what is used in the analysis. This advocates for a more thor-
ough analysis of this dataset that lies beyond the scope of this 
manuscript.
Functional Annotation and Classification of Differentially Expressed 
Genes Induced During Respiratory Syncytial Virus and Rhinovirus 
Infection
By using g:Profiler and InnateDB pathway analysis, we 
revealed the functional significance of the identified DEGs in 
all RSV infection cases and in hRV. Innate immune responses, 
ie, interferon (IFN) signaling (IFN-α/β and IFN-γ signaling), 
cytokine signaling, and the pathway related to Th17 cell pop-
ulation, ie, interleukin (IL)-23-mediated signaling, were the 
main pathways enriched from up-regulated genes in both NP 
swabs and blood of RSV cases. In contrast, the down-regu-
lated genes were involved in specific metabolic processes 
of different cell types from each compartment (Figure  2a). 
For hRV infection, all DEGs in blood arrays were up-regu-
lated and enriched in pathways related to (1) innate immune 
responses, (2) proinflammatory cytokine production (IL-1 
signaling pathway), and (3) Th17 cell population (IL-23-
mediated signaling) (Figure  2b); however, there were no 
enriched pathways related to Th17 cell populations in hRV 
NP arrays.
Gene Coexpression Network Analysis During Respiratory Syncytial Virus 
Infection
We explored the coexpressed network modules in the RSV 
host response by using WGCNA, and we identified 20 and 37 
coexpressed network modules in NP swabs and blood during 
RSV infection, respectively (Figure 3a and b). For hRV infec-
tion, 22 and 16 coexpressed network modules in NP swabs and 
blood were identified, respectively (Supplementary Figure 4a 
and b). We focused on the RSV-coexpressed gene modules 
that were significantly correlated with the course of illness, ie, 
acute versus early recovery, and with at least 3 clinical traits 
Blood samples Nasal samples Blood samples Nasal samples
Blood samples
hRV infection
64 13 278 127 36 836
41 43 376 85 44 671
RSVsi infection
RSVco infection RSV infection
Nasal samples Blood samples Nasal samples
Figure 1. Comparison of differentially expressed genes obtained with nasopharyngeal (NP) swabs and blood samples. Abbreviations: hRV, rhinovirus; RSV, respiratory 
syncytial virus; RSVco, RSV coinfection group; RSVsi, single-RSV group. 
Table 2. Number of DEGs (FDR <0.05 and |FC| ≥2) Identified With NP and Blood Samples (Early Recovery Versus Acute Phase)
Type of sample Blood Samples NP Samples
Patient Group hRV RSVco RSVsi RSV hRV RSVco RSVsi RSV
Number of 
samples
60 30 76 106 60 30 76 106
Number of  
DEGs
92 (0 down, 
92 up)
106 (14 down,  
92 up)
182 (73 down, 
109 up)
155 (38 down, 
117 up)
325 (297 down, 
28 up)
479 (212 down, 
267 up)
992 (622 down, 
370 up)
825 (512 down, 
313 up)
Abbreviations: DEGs, diffentially expressed genes; FC, fold change; FDR, false discovery rate; hRV, rhinovirus; NP, nasopharyngeal; RSV, respiratory syncytial virus; RSVco, RSV coinfection 
group; RSVsi, single-RSV group.
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related to severity, RSV subgroup, and RSV load. Hence, 7 of 
20 modules in NP swabs and 5 of 37 modules in blood were 
selected and named as selected significantly coexpressed gene 
modules.
Identification of Hub Genes Involved in Respiratory Syncytial Virus (RSV) 
Pathogenesis Through RSV Pathogenesis Networks and Differentially 
Expressed Genes Identified During RSV Infection
We hypothesized that the common set of genes between the 
DEGs identified over the course of the RSV infection and 
the significantly coexpressed gene modules could reveal 
leading biological pathways and identify key genes related to 
pathogenesis. Hence, we compared the selected significantly 
coexpressed gene modules and DEG lists (Supplementary 
Figure 5). Expression of these modules was either positively 
correlated with viral load, severity, and blood neutrophil 
counts or inversely correlated with time, load, and severity 
(Table 3).
The RSV “severe” network (severe NP network) and the 
RSV “nonsevere” network (nonsevere NP network) in NP 
arrays were built from 309 genes and 498 genes, respectively 
(Supplementary Table 3, Figure 4). The RSV severe network in 
blood arrays (severe blood network) and the RSV nonsevere 
network were built from 118 genes and 37 genes, respectively 
(Supplementary Table 6, Figure 4). Genes in the severe and non-
severe networks were either up-regulated or down-regulated, 
respectively, at RSV acute infection in both sites (NP swabs and 
blood). However, only gene ORM1 (orosomucoid 1) in severe 
NP network was down-regulated during RSV acute infection 
(logFC = −1.2, adjusted P-value = 2.7E-03).
To assess the interaction between the DEGs in the selected 
modules, a PPI network was explored and visualized using 
NetworkAnalyst. As shown in Figure 4, the severe NP network 
consisted of 1803 nodes and 2894 edges, and the severe blood 
network consisted of 1027 nodes and 1323 edges. In the PPI 
networks, the nodes with a high degree of connection were 
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Figure 2. (a) Pathway enriched in differentially expressed genes (DEGs) of nasopharyngeal (NP) swabs and blood in respiratory syncytial virus (RSV) infection using 
InnateDB. (b) Pathway enriched in DEGs of NP swabs and blood in rhinovirus infection. (a and b) The module-trait relationships with the correlation coefficients and P values. 
The strength of the correlation is colored by different intensities of red (positive correlation) and blue (negative correlation).
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defined as hub proteins. The topological analysis of these 2 
severe networks revealed HIST1H4E (histone cluster 1 H4 fam-
ily member E) (logFC = 1.56, P = 2.8E-10, degree = 231), IL-7 
receptor (IL7R) (logFC = 1.46, P = 8.8E-10, degree = 199), and 
IFN-stimulated gene 15 (ISG15) (logFC  =  1.99, P  =  1.7E-09, 
degree = 188) (in NP samples) as the most significant hubs in 
the severe NP network; however, ISG15 (logFC = 1.46, P = 3.1E-
07, degree  =  188), B cell lymphoma 6 (BCL6) (logFC  =  1.13, 
P  =  6.8E-08, degree  =  139), and phospholipid scramblase 1 
(PLSCR1) (logFC = 1.45, P = 4.0E-10, degree = 84) in the severe 
blood network were hub genes positively associated with both 
RSV load and severity.
Comparing these two networks with the recently published 
RSV-host interaction network [39], we found that only 3 
DEGs from the severe NP network interacted directly with a 
viral RSV protein: (1) SLC7A5 (solute carrier family 7 member 
5) (logFC = 1.19, P = 1.39E-07, degree = 5) interacts with the 
RSV nonstructural protein 1 (NS1); (2) DDX58 (DExD/H-box 
helicase 58) (logFC = 1.38; P = 3.3E-09, degree = 56) and (3) 
IFN induced with helicase C domain 1 (IFIH1) (logFC = 1.28; 
P = 6.6E-09, degree = 22) interact directly with the RSV viral 
N protein.
DISCUSSION
To our knowledge, this is the first study examining the host 
gene expression response in children with LRTI with RSV or 
hRV over the course of infection from 2 compartments, ie, NP 
swabs and blood samples, representing in situ and systemic 
responses, respectively. Using an unbiased analytical strategy, 
we found that RSV infection induced similar pathways in both 
compartments, whereas for hRV infection, no common path-
ways were shared between the two compartments. For RSV 
infection, the overall transcriptional responses in blood were 
reduced in comparison to the NP compartment, with fewer 
DEGs and enriched pathways as well as lower fold changes. 
This finding highlights the localized response to RSV infec-
tion and the importance of studying the NP compartment, 
which has also been previously shown to have a similar gene 
expression pattern as bronchial epithelium in response to cig-
arette smoking [40, 41] or in inflammatory responses [42]. 
This study invites further explorations on the utility of NP 
specimens as a noninvasive surrogate for bronchial cells in 
a larger-scale gene expression analysis using the BeadArray 
platform [20, 23, 43].
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Fig 2. Continued
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Figure 3. (a) Weighted gene coexpression network analysis (WGCNA) heatmap for gene coexpression network analysis in respiratory syncytial virus (RSV) nasopharyngeal 
(NP) arrays: identified modules and clinical trait. (b) WGCNA heatmap for gene coexpression network analysis in RSV blood arrays: identified modules and clinical trait. Each 
box represents the module and clinical trait relationships with the correlation coefficients and P values. The strength of the correlation is colored by different intensities of 
red (positive correlation) and blue (negative correlation). The x-axis represents clinical traits and the y-axis represents coexpressed modules. (*) shows the selected modules 
that were significantly correlated with the course of illness, ie, acute versus early recovery, and with at least 3 clinical traits related to severity, RSV subgroup, and RSV load.
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Respiratory syncytial virus infection induced a different host 
response from hRV in terms of local and systemic responses. 
Furthermore, RSV appears to be the dominant pathogen during 
coinfections because similar patterns were observed in RSV coinfec-
tion cases. Others also found that in bacterial carriages, the response 
to RSV was also predominant and independent of the microbiome 
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Figure 3. Continued
Downloaded from https://academic.oup.com/jid/article-abstract/217/1/134/4265606
by London School of Hygiene & Tropical Medicine user
on 26 January 2018
142 • JID 2018:217 (1 January) • Do et al
composition in NP [44]. We could not confirm this observation in 
our study, because we did not attempt to detect bacteria in NP sam-
ples. In contrast to hRV infection, we found that RSV induced a large 
number of chemokines/cytokines and IFN responses that still pre-
dominated on day 4 after illness onset. Others observed only a few of 
these responses in lung tissue from experimental mouse infections 
on day 5 [13] and after 24-hour post-RSV challenge in adult patients 
[14]. This highlighted the limitations of experimental infections in 
animals or human volunteers, because it may not reliably reflect RSV 
pathogenesis of severe disease in young children. The top 3 of up-reg-
ulated DEGs found in our study (chemokine genes [CCL8, CXCL10, 
and CXCL11] [fold change 16–32]; CD177 [molecule expressed on 
neutrophil]; otoferlin [OTOF]; and caspase 5 [CASP5; involved in 
apoptotic cell death] [fold change 4–8]) highlighted the role of neu-
trophil activation, overexpression of IFN, and other innate immune 
genes that have previously been reported in RSV infection [22].
Also of note, for RSV infection only, WGCNA showed clear 
clusters of modules that significantly correlated with sever-
ity (Figure  3a and b), whereas for hRV infection, we did not 
observe this pattern (Supplementary Figure 4). The ISG15 was 
up-regulated in both blood and NP samples in acute RSV infec-
tion and belongs to modules significantly correlated with viral 
load. The positive correlation of the expression of ISG15 and 
RSV load has recently been observed in an ex vivo model of 
respiratory epithelium and confirmed in clinical samples of 
RSV-infected children [45]. Another gene positively correlating 
with RSV load and disease severity and significantly up-regu-
lated in the acute phase was BCL6, which was found as a hub 
gene in blood. B cell lymphoma 6 mediates the development 
of T follicular helper (Tfh) cells and is an important regulator 
of Th2 responses. More importantly, it has been suggested that 
the short-lived, protective, neutralizing antibody response after 
RSV infection is due to an impaired development of Tfh cells, 
which are required for plasmablast generation and subsequent 
antibody formation [46]. B cell lymphoma 6 overexpression has 
recently been shown for the first time to promote inflammatory 
responses, but it inhibits antiviral signaling through repressing 
the IRF7 promoter activity [47]. The down-regulation of the 
ORM1 gene in the severe NP network suggests a possible 
correlation between severe RSV infection and uncontrolled 
inflammatory cytokine production. However, ORM1 is an 
anti-inflammatory molecule that inhibits neutrophil activation, 
complement activity, and modulates proinflammatory cytokine 
secretion by monocytes [48].
Our study has limitations. Our patients were all hospitalized 
with severe illness and not representative for the entire spectrum 
of the RSV infection phenotype, and gene expression patterns 
may not be similar for milder cases managed as outpatients. Only 
Table 3. Characteristics of the Selected Significant Coexpressed Network Modules of Severe and Nonsevere Group in NP Swabs and Blood
Group Sample Type
WGCNA Module 
Selected
Correlation of Gene 
Expression With  
Phase of Infections and DOI
Correlation of Gene 
Expression With  
Severity and RSV Load Top 3 GO- Functional Enrichment Pathway
Severe NP Turquoise Negative Positive Immune response, immune system process, 
defense response
Brown Negative Positive Immune response, immune system pro-
cess, defense response, innate immune 
response
Dark-turquoise Negative Positive Immune system process, immune response, 
T-cell aggregation
Green Positive Negative Regulation of signal transduction, enzyme- 
linked receptor protein signaling pathway
Blood Floral-white Negative Positive Response to type I interferon, cellular 
response to type I interferon, innate 
immune response
Black Negative Positive Immune system process, response to 
stress, defense response
Light-pink4 Negative Positive Vesicle-mediated transport, Toll-like receptor 
4 signaling pathway, endomembrane sys-
tem organization
Nonsevere NP Blue Positive Negative Cilium morphogenesis, cilium assembly, cil-
ium organization
Yellow Positive Negative Oxoacid metabolic process, carboxylic acid 
metabolic process, organic acid metabolic 
process
Royal-blue Positive Negative Mitotic cell cycle, cell cycle
Blood Turquoise Positive Negative Heme metabolic process, heme biosynthe-
sis process, locomotion
Antique-white4 Positive Negative Endothelial cell-cell adhesion, leukotriene 
metabolic process
Abbreviations: DOI, day of illness; GO, gene ontology; NP, nasopharyngeal swabs; RSV, respiratory syncytial virus; WGCNA, weighted gene coexpression network analysis. 
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83/632 patients from the original cohort were selected for the 
host expression analysis. The selection was based on availability 
of paired samples and RNA quality for microarray. The demo-
graphic characteristics of this subset of patients were not differ-
ent from the original cohort. On the other end of the spectrum, 
because mortality was 0%, we also did not have samples from 
patients who died. A broader spectrum of clinical severity will 
facilitate the identification of host markers associated with RSV 
severity. Using steroids can have an impact on the innate immune 
response. However, the number of patients under this treatment 
is small (Table 1), and so we were unable to explore this impact. 
Although our aim was not to identify biomarkers for RSV and 
hRV infection, a healthy control group would provide us a base-
line to correlate the dispersion of the gene expression induced by 
viral infection and disease severity. Despite the fact that the accu-
racy of gene expression data from BeadArray platform is highly 
improved by using multiple probes for each gene, measuring pro-
teins derived from highly expressed genes, ie, cytokines/chemo-
kines, in blood and in prenasal swabs is required to confirm our 
observations and the potential markers for studying RSV severity.
A
Figure 4. (a) Analysis of acute network in nasopharyngeal (NP). Network analysis using common genes between modules positively correlated with respiratory syncytial virus 
(RSV) load/severity and those differentially expressed genes (DEGs) identified between acute versus early recovery phase. Red and green nodes represent genes showing increased 
and decreased expression, respectively. Nodes in gray are direct interaction partners. The size of nodes is proportional to their degree values. (b) Analysis of acute network in blood. 
Network analysis using common genes between modules positively correlated with RSV load/severity and those DEGs identified between acute versus early recovery phase. Nodes 
in gray are direct interaction partners. The size of nodes is proportional to their degree values, and the color of nodes are proportional to their betweenness centrality values.
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CONCLUSIONS
In conclusion, the present study showed that RSV infection 
induces strong and prolonged innate immune responses with 
overlap between local and systemic samples, which was not 
observed in hRV infection. In severe RSV cases, RSV may cause 
an unbalanced inflammatory response and interact with the 
BCL6 gene to escape the host immune response.
Supplementary Data
Supplementary materials are available at The Journal of 
Infectious Diseases online. Consisting of data provided by the 
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author.
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